Metycylinooporny Staphylococcus aureus [MRSA] - wystepowanie u zwierzat a potencjalne zagrozenia zdrowia czlowieka

• Autorzy: Kania I , Osek J.

Warianty tytułu

EN

Methicillin-resistant Staphylococcus aureus [MRSA] - occurrence in animals and potential threat of human health

• Języki publikacji: PL

Abstrakty

EN

Due to the widespread prevalence of methicillin-resistant Staphylococcus aureus (MRSA) it has been included in the group of microorganisms causing severe human and animal infections. These bacteria occur in cattle, sheep, pigs, horses, dogs, cats, rabbits and poultry. The main diseases that are caused by S. aureus are dermatosis, mastitis, arthritis and urinary tract infections. People may develop more serious complications; e.g. pneumonia, endocarditis, bacteraemia. Moreover, these microorganisms are frequently connected with postoperative wound infections. The first MRSA strains emerged in the early 1960s after the acquisition of the methicillin resistance gene mecA, which is carried by the staphylococcal chromosomal cassette mec (SCCmec). The mecA gene encodes for a penicillin-binding protein (PBP2a) which has a low affinity to β-lactam antibiotics. Epidemiological data suggests that MRSA isolates from various animal species are genetically very similar or even indistinguishable from human isolates. The transfer of MRSA strains can occur between animals and humans as well as vice versa. The antibiotics that are effective for the treatment of infections caused by MRSA are still glycopeptides: vancomycin and teicoplanin, mupirocin and linezolid. However, there are already strains resistant to all known antibiotic groups. MRSA may be a source of antibiotic resistance genes and contribute to the spread of drug-resistance genetic elements to other disease-causing microorganisms.

Słowa kluczowe

PL

gronkowiec zlocisty; Staphylococcus aureus; gronkowce oporne na metycyline; wystepowanie; szczepy odzwierzece; zwierzeta gospodarskie; wykrywanie; lekoopornosc; chorobotworczosc; nosicielstwo; czlowiek; zagrozenia zdrowia

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2009
• Tom: 65
• Numer: 05
• Opis fizyczny: s.301-305,bibliogr.

Twórcy

autor

Kania I

• Panstwowy Instytut Weterynaryjny - Panstwowy Instytut Badawczy, Al.Partyzantow 57, 24-100 Pulawy

autor

Osek J.

Bibliografia

• 1.Aires de Sousa M., de Lencastre H.: Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones. FEMS Immunol. Med. Microbiol. 2004, 40, 101-111.
• 2.Bednarek M., Majda-Stanisławska E.: Występowanie szczepów metycylinoopornych gronkowców złocistych (MRSA) oraz trudności w leczeniu wywołanych przez nie infekcji u dzieci hospitalizowanych w klinice. Przegl. Epidemiol. 2006, 60, 49-52.
• 3.Bukharie H. A., Abdelhadi M. S., Saeed I. A., Rubaish A. M., Larbi E. B.: Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diagn. Microbiol. Infect. Dis. 2001, 40, 1-4.
• 4.Chaberny I. F., Ziesing S., Mattner F., Barwolff S., Brandt Ch., Eckmanns T., Ruden H., Sohr D., Weist K., Gastmeier P.: The burden of MRSA in four German university hospitals. Int. J. Hyg. Environ. Health 2005, 208, 447-453.
• 5.Decyzja Komisji z dnia 20 grudnia 2007 r. w sprawie wkładu finansowego Wspólnoty na rzecz badania dotyczącego występowania Salmonella spp. oraz opornego na metycylinę gronkowca złocistego (Staphylococcus aureus) w stadach świń hodowlanych prowadzonego w państwach członkowskich. Dz. U. UE L 14 z 17.1.2008, 10-25.
• 6.Denton M.: Zakażenia gronkowcem złocistym opornym na metycylinę (MRSA) u chorych na mukowiscydozę. MATIO 2001, 12, 7-9.
• 7.Duijkeren E. van, Ikawaty R., Broekhuizen-Stins M. J., Jansen M. D., Spalburg E. C., de Neeling A. J., Allaart J. G., van Nes A., Wagenaar J. A., Fluit A. C.: Transmission of methicillin-resistant Staphylococcus aureus strains between different kinds of pig farms. Vet. Microbiol. 2008, 126, 383-389.
• 8.Gemmell C. G., Edwards D. I., Fraise A. P., Gould F. K., Ridgway G. L., Warren R. E.: Guidelines for de prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J. Antimicrob. Chemother. 2006, 57, 589-608.
• 9.Goni P., Vergara Y., Ruiz J., Albizu I., Vila J., Gomez-Lus R.: Antibiotic resistance and epidemiological typing of Staphylococcus aureus strains from ovine and rabbit mastitis. Int. J. Antimicrob. Agents 2004, 23, 268-272.
• 10.Hemaiswarya S., Kruthiventi A. K., Doble M.: Synergism between natural products and antibiotics against infectious diseases. Phytomed. 2008, 15, 639-652.
• 11.Irish D., Eltringham I., Teall A., Pickett H., Farelly H., Reith S., Woodford N., Cookson B.: Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin. J. Hosp. Infect. 1998, 39, 19-26.
• 12.Karas J. A., Enoch D. A., Emery M. M.: Community-onset healthcare-associated MRSA bacteraemia in a district general hospital. J. Hosp. Infect. 2006, 62, 480-486.
• 13.Khanna T., Friendship R., Dewey C., Weese J. S.: Methicillin-resistant Staphylococcus aureus colonization in pigs and pig farmers. Vet. Microbiol. 2008, 128, 298-303.
• 14.Lee J. H.: Methicillin (oxacillin)-resistant Staphylococcus aureus strains isolated from major food animals and their potential transmission to humans. Appl. Environ. Microbiol. 2003, 69, 6489-6494.
• 15.Leonard F. C., Markey B. K.: Meticillin-resistant Staphylococcus aureus in animals: A review. Vet. J. 2008, 175, 27-36.
• 16.Lewis H. C., Molbak K., Reese C., Aarestrup F. M., Selchau M., Sorum M., Skov R. L.: Pigs as source of methicillin-resistant Staphylococcus aureus CC398 infections in humans. Denmark. Emerg. Infect. Dis. 2008, 14, 1383-1389.
• 17.Malik S., Peng H., Barton M. D.: Partial nucleotide sequencing of the mecA genes of Staphylococcus aureus isolates from cats and dogs. J. Clin. Microbiol. 2006, 44, 413-416.
• 18.Mądry K.: Nowe antybiotyki. Współczesna Onkol. 2004, 2, 52-57.
• 19.Moellering R. C., Graybill J. R., McGowan J. E., Corey L.: Antimicrobial resistance prevention initiative - An update: Proceedings of an expert panel on resistance. Am. J. Med. 2007, 120, S4-S25.
• 20.Neeling A. J. de, van de Broek M. J. M., Spalburg E. C., van Santen-Verheuvel M. G., Dam-Deisz W. D. C., Boshuizen H. C., van de Giessen A. W., van Duijkeren E., Huijsdens X. W.: High prevalence of methicillin resistant Staphylococcus aureus in pigs. Vet. Microbiol. 2007, 122, 366-372.
• 21.O'Mahony R., Abbott Y., Leonard F. C., Markey B. K., Quinn P. J., Pollock P. J., Fanning S., Rossney A. S.: Methicillin-resistant Staphylococcus aureus (MRSA) isolated from animals and veterinary personnel in Ireland. Vet. Microbiol. 2005, 109, 285-296.
• 22.Pejsak Z., Truszczyński M.: Wskazania do monitorowania występowania u zwierząt gronkowca złocistego opornego na metycylinę. Życie Wet. 2008, 83, 648-650.
• 23.Rankin S., Roberts S., O'Shea K., Maloney D., Lorenzo M., Benson C. E.: Panton valentine leukocidin (PVL) toxin positive MRSA strains isolated from companion animals. Vet. Microbiol. 2005, 108, 145-148.
• 24.Rich M., Deighton L., Roberts L.: Clindamycin-resistant in methicillin-resistant Staphylococcus aureus isolated from animals. Vet. Microbiol. 2005, 111, 237-240.
• 25.Robak P., Robak T.: Zastosowanie antybiotyków glikopeptydowych u chorych z gorączką neutropeniczną. Acta Haemat. Pol. 2006, 3, 317-328.
• 26.Roberts S., O'Shea K., Morris D., Robb A., Morrison D., Rankin S.: A real-time PCR assay to detect the Panton Valentine Leukocidin toxin in staphylococci: screening Staphylococcus schleiferi subspecies coagulans strains from companion animals. Vet. Microbiol. 2005, 107, 139-144.
• 27.Schmitz F. J., Jones M. E.: Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices? Int. J. Antimicrob. Agents 1997, 9, 1-19.
• 28.Weese J. S., Dick H., Willey B. M., McGeer A., Kreiswirth B. N., Innis B., Low D. E.: Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet. Microbiol. 2006, 115, 148-155.